» Articles » PMID: 35547469

Detection of Newly Emerging Psychoactive Substances Using Raman Spectroscopy and Chemometrics

Overview
Journal RSC Adv
Specialty Chemistry
Date 2022 May 13
PMID 35547469
Authors
Affiliations
Soon will be listed here.
Abstract

A novel approach for the identification of New Psychoactive Substances (NPS) by means of Raman spectroscopy coupled with Principal Components Analysis (PCA) employing the largest dataset of NPS reference materials to date is reported here. Fifty three NPS were selected as a structurally diverse subset from an original dataset of 478 NPS compounds. The Raman spectral profiles were experimentally acquired for all 53 substances, evaluated using a number of pre-processing techniques, and used to generate a PCA model. The optimum model system used a relatively narrow spectral range (1300-1750 cm) and accounted for 37% of the variance in the dataset using the first three principal components, despite the large structural diversity inherent in the NPS subset. Nonetheless, structurally similar NPS (, the synthetic cannabinoids FDU-PB-22 & NM-2201) grouped together in the PCA model based on their Raman spectral profiles, while NPS with different chemical scaffolds (, the benzodiazepine flubromazolam and the cathinone α-PBT) were well delineated, occupying markedly different areas of the three-dimensional scores plot. Classification of NPS based on their Raman spectra (, chemical scaffolds) using the PCA model was further investigated. NPS that were present in the initial dataset of 478 NPS but were not part of the selected 53 training set (validation set) were observed to be closely aligned to structurally similar NPS within the generated model system in all cases. Furthermore, NPS that were not present in the original dataset of 478 NPS (test set) were also shown to group as expected in the model (, methamphetamine and -ethylamphetamine). This indicates that, for the first time, a model system can be applied to potential 'unknown' psychoactive substances, which are new to the market and absent from existing chemical libraries, to identify key structural features to make a preliminary classification. Consequently, it is anticipated that this study will be of interest to the broad scientific audience working with large structurally diverse chemical datasets and particularly to law enforcement agencies and associated scientific analytical bodies worldwide investigating the development of novel identification methodologies for psychoactive substances.

Citing Articles

Novel Thermosensitive and Mucoadhesive Nasal Hydrogel Containing 5-MeO-DMT Optimized Using Box-Behnken Experimental Design.

Miranda P, Castro A, Diaz P, Minini L, Ferraro F, Paulsen E Polymers (Basel). 2024; 16(15).

PMID: 39125174 PMC: 11314354. DOI: 10.3390/polym16152148.


Drug classification with a spectral barcode obtained with a smartphone Raman spectrometer.

Kim U, Lee S, Kim H, Roh Y, Han S, Kim H Nat Commun. 2023; 14(1):5262.

PMID: 37644026 PMC: 10465478. DOI: 10.1038/s41467-023-40925-3.


Detection of newly emerging psychoactive substances using Raman spectroscopy and chemometrics.

Calvo-Castro J, Guirguis A, Samaras E, Zloh M, Kirton S, Stair J RSC Adv. 2022; 8(56):31924-31933.

PMID: 35547469 PMC: 9085863. DOI: 10.1039/c8ra05847d.


Interpol review of controlled substances 2016-2019.

Jones N, Comparin J Forensic Sci Int Synerg. 2021; 2:608-669.

PMID: 33385148 PMC: 7770462. DOI: 10.1016/j.fsisyn.2020.01.019.


Performance evaluation of handheld Raman spectroscopy for cocaine detection in forensic case samples.

Kranenburg R, Verduin J, de Ridder R, Weesepoel Y, Alewijn M, Heerschop M Drug Test Anal. 2020; 13(5):1054-1067.

PMID: 33354929 PMC: 8248000. DOI: 10.1002/dta.2993.


References
1.
Kellett K, Broome J, Zloh M, Kirton S, Fergus S, Gerhard U . Small molecule recognition of mephedrone using an anthracene molecular clip. Chem Commun (Camb). 2016; 52(47):7474-7. DOI: 10.1039/c6cc03404g. View

2.
Brandt S, King L, Evans-Brown M . The new drug phenomenon. Drug Test Anal. 2014; 6(7-8):587-97. DOI: 10.1002/dta.1686. View

3.
Maheux C, Copeland C . Chemical analysis of two new designer drugs: buphedrone and pentedrone. Drug Test Anal. 2011; 4(1):17-23. DOI: 10.1002/dta.385. View

4.
Stewart S, Bell S, Fletcher N, Bouazzaoui S, Ho Y, Speers S . Raman spectroscopy for forensic examination of β-ketophenethylamine "legal highs": reference and seized samples of cathinone derivatives. Anal Chim Acta. 2011; 711:1-6. DOI: 10.1016/j.aca.2011.10.018. View

5.
Regester L, Chmiel J, Holler J, Vorce S, Levine B, Bosy T . Determination of designer drug cross-reactivity on five commercial immunoassay screening kits. J Anal Toxicol. 2014; 39(2):144-51. DOI: 10.1093/jat/bku133. View